| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/07/2002 | US6383766 Reduced cortisol conjugates |
| 05/07/2002 | US6383765 Polypeptides of feline T-cell lymphotropic lentivirus |
| 05/07/2002 | US6383761 Methods and compositions for identifying modulators of G-protein-coupled receptors |
| 05/07/2002 | US6383760 Contacting receptor with test compound, then determining if compound binds to receptor |
| 05/07/2002 | US6383756 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
| 05/07/2002 | US6383754 Incubating nucleic acid with cleaving reagents, mixing with offset adaptors that couple with nucleic acid fragments, incubating nucleic acids with cleaving reagents that create sticky ends, mixing and coupling adaptor-indexers to fragments |
| 05/07/2002 | US6383751 Assessing marbling score of cattle by testing animal for presence or absense of allele of 5' untranslated region of gene encoding thyroglobin; presence of allele 3 indicates high score, homozygositiy for allele 2 indicates low score |
| 05/07/2002 | US6383748 Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same |
| 05/07/2002 | US6383745 Methods of screening for anti-microbial utilizing aarC and compositions thereof |
| 05/07/2002 | US6383743 Method for serial analysis of gene expression |
| 05/07/2002 | US6383742 Biochips having sheets made to form layers, each sheet having two dimensions of attatched oligonucleotide probes; diagnosis; forensics; genetic mapping |
| 05/07/2002 | US6383741 Administering an attenuation virus |
| 05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
| 05/07/2002 | US6383738 Herpes simplex virus ORF P is a repressor of viral protein synthesis |
| 05/07/2002 | US6383737 Consisting of a polynucleotide encoding the polypeptide comprising amino acid 1 to 578 of a specific amino acid sequence, a polynucleotide capable of hybridizing to above polynuceotide and a fragment of both polynucleotides |
| 05/07/2002 | US6383496 Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype |
| 05/07/2002 | US6383488 Pre-M/M epitopes of dengue virus, synthetic peptides, chimeric proteins and their use |
| 05/07/2002 | US6383487 Antitumor |
| 05/07/2002 | US6383486 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
| 05/07/2002 | US6383474 Carotenoid preparation |
| 05/07/2002 | US6383393 Adsorption |
| 05/07/2002 | US6383069 Methods and apparatus for performing processing operations on a slaughtered animal or part thereof |
| 05/07/2002 | CA2230059C Propargylethoxyamino nucleotides |
| 05/07/2002 | CA1341357C Platelet-specific chimeric immunoglobulin |
| 05/02/2002 | WO2002035240A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | WO2002035237A2 Method for in vivo identification of intracellular epitopes |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034953A2 Detection and quantification of human herpes viruses |
| 05/02/2002 | WO2002034951A2 Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
| 05/02/2002 | WO2002034950A2 Immobilization of biopolymers to aminated substrates by direct adsorption |
| 05/02/2002 | WO2002034947A2 Detecting specific nucleotide sequences |
| 05/02/2002 | WO2002034946A2 Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof |
| 05/02/2002 | WO2002034945A2 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | WO2002034944A1 High precision and intellectual biochip arrayer having function of respotting |
| 05/02/2002 | WO2002034942A2 Nucleic acid amplification-based methods for the determination of a methylation profile and reagents therefor |
| 05/02/2002 | WO2002034941A1 Method for screening active molecules for treating and preventing atherosclerotic lesions and its uses |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034935A2 In vitro selection of signaling aptamers |
| 05/02/2002 | WO2002034932A1 A process of preparing a derivatised saccharide |
| 05/02/2002 | WO2002034930A2 Methods of use of regulators of g-protein signaling to modulate dopamine signaling and dopamine-related neurobehavior |
| 05/02/2002 | WO2002034929A2 Expression vectors and uses thereof |
| 05/02/2002 | WO2002034928A1 Non-human transgenic animal expressing ca-ahr |
| 05/02/2002 | WO2002034927A2 Plant genes that confer resistance to strains of magnaporthe grisea having avr1 co39 cultivar specificity gene |
| 05/02/2002 | WO2002034926A2 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars |
| 05/02/2002 | WO2002034925A1 Use of bacterial acetate kinase and their genes for protection of plants against different pathogens |
| 05/02/2002 | WO2002034924A2 Expression cassette used for the transgenic expression of nucleic acids in the embryonic epidermis and/or flower of plants |
| 05/02/2002 | WO2002034923A2 Monocotyledon plant cells and plants which synthesise modified starch |
| 05/02/2002 | WO2002034922A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/02/2002 | WO2002034921A2 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE |
| 05/02/2002 | WO2002034920A2 Regulation of human ceruloplasmin-like protein |
| 05/02/2002 | WO2002034919A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 05/02/2002 | WO2002034918A2 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 05/02/2002 | WO2002034917A2 Secreted alpha-helical cytokine-like protein zlmda24 |
| 05/02/2002 | WO2002034916A2 Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034914A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034912A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis |
| 05/02/2002 | WO2002034911A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | WO2002034910A2 Method for modulating granzyme b uptake and for identifying modulators thereof |
| 05/02/2002 | WO2002034909A2 Engineered chimera of hiv protein fragments and uses thereof |
| 05/02/2002 | WO2002034908A2 Method for temporally controlling antisense-mediated gene inactivation |
| 05/02/2002 | WO2002034907A1 Method of synthesizing single-stranded nucleic acid |
| 05/02/2002 | WO2002034906A2 Method for exposing peptides and polypeptides on the cell surface of bacteria |
| 05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | WO2002034899A2 Tec kinase assay |
| 05/02/2002 | WO2002034895A2 Novel aggrecanase molecules |
| 05/02/2002 | WO2002034894A2 Plant promoter providing high levels of gene expression in fruits |
| 05/02/2002 | WO2002034893A2 Synthetic viruses and uses thereof |
| 05/02/2002 | WO2002034891A2 Immortalized preosteoblasts and method for their production |
| 05/02/2002 | WO2002034886A2 Isolation of binding proteins with high affinity to ligands |
| 05/02/2002 | WO2002034881A2 Compositions and methods for the discovery and selection of biological information |
| 05/02/2002 | WO2002034879A2 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 05/02/2002 | WO2002034789A1 Monoclonal antibodies directed against hepatitis b viruses |
| 05/02/2002 | WO2002034788A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034782A2 Endozepine-like polypeptide nov1 and nucleic acid encoding the same |
| 05/02/2002 | WO2002034778A2 Baseb209 polypeptides and polynucleotides from haemophilus influenzae |
| 05/02/2002 | WO2002034776A2 Epitopes of pai-1 |
| 05/02/2002 | WO2002034774A2 Bacillus thuringiensis proteins and variants thereof with pesticidal activity against coleopterans |
| 05/02/2002 | WO2002034772A2 Novel compounds |
| 05/02/2002 | WO2002034770A1 Identification of hla-dr restricted hcv epitopes |
| 05/02/2002 | WO2002034769A2 Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 05/02/2002 | WO2002034768A2 Polypeptides and polynucleodides from haemophilus influenzae and their use |
| 05/02/2002 | WO2002034763A2 Mucin comprising vehicle for the transport of biologically-active agents |
| 05/02/2002 | WO2002034762A2 Method for generating a library of oligonucleotides comprising a controlled distribution of mutations |
| 05/02/2002 | WO2002034296A1 A novel gene therapy agent for haemophilia b and its preparation method |
| 05/02/2002 | WO2002034291A2 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 05/02/2002 | WO2002034288A2 Vaccine for treating allergy |
| 05/02/2002 | WO2002034284A2 Methods of therapy for hiv infection |
| 05/02/2002 | WO2002034280A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 05/02/2002 | WO2002034201A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 05/02/2002 | WO2002034119A2 Vaccine immunotherapy for immune suppressed patients |
| 05/02/2002 | WO2002034042A2 Knockout mice thyroid stimulating hormone receptor (tsh-r) gene |
| 05/02/2002 | WO2002034041A1 Senescence marker protein 30-defective nonhuman animal, antibody and method of constructing the same |
| 05/02/2002 | WO2002034040A2 Method for generating transgenic fish embryos using an episomal vector system |
| 05/02/2002 | WO2002034035A1 Genetic insulator for preventing influence by another gene promoter |
| 05/02/2002 | WO2002034034A1 Transgenic plants with reduced expression of endogenous phytochrome a, exhibiting improved rooting, and methods for their production |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |